Elbert P. Trulock

Elbert P. Trulock's AcademicInfluence.com Rankings

Elbert P. Trulock

Medical

#3161

World Rank

#3616

Historical Rank

Surgery

#263

World Rank

#322

Historical Rank

medical Degrees

Elbert P. Trulock

Philosophy

#9096

World Rank

#12602

Historical Rank

Logic

#6087

World Rank

#7569

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Elbert P. Trulock Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Elbert P. Trulock's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. (1995) (882)
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006. (2006) (595)
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. (1996) (521)
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. (2007) (507)
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. (2007) (469)
Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. (1996) (448)
The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003. (2003) (396)
International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). (1998) (392)
Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. (2005) (378)
Clinical Outcome following Nerve Allograft Transplantation (2001) (374)
The registry of the international society for heart and lung transplantation: nineteenth official report-2002. (2002) (356)
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004. (2004) (356)
Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007. (2007) (337)
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. (2007) (332)
Improved technique for bilateral lung transplantation: rationale and initial clinical experience. (1990) (327)
Right and left ventricular dysfunction in patients with severe pulmonary disease. (1998) (316)
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. (2006) (288)
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. (2004) (253)
Interventional and surgical modalities of treatment for pulmonary arterial hypertension. (2004) (248)
Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005. (2005) (238)
Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. (1995) (232)
Inhaled nitric oxide reduces human lung allograft dysfunction. (1996) (224)
Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report--2007. (2006) (210)
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. (2010) (208)
Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. (1995) (204)
Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. (1994) (201)
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. (1998) (199)
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. (1999) (197)
The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. (1992) (190)
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. (2004) (189)
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation (1995) (181)
Cytomegalovirus Infection and Pneumonitis: Impact after Isolated Lung Transplantation (1993) (178)
The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. (2010) (167)
Acute antibody-mediated rejection after lung transplantation. (2013) (158)
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. (2011) (157)
The Significance of a Single Episode of Minimal Acute Rejection after Lung Transplantation (2005) (151)
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. (1998) (150)
Thirteen-year experience in lung transplantation for emphysema. (2002) (146)
The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report--2003. (2003) (146)
Immunological link between primary graft dysfunction and chronic lung allograft rejection. (2008) (146)
Improved airway healing after lung transplantation. An analysis of 348 bronchial anastomoses. (1995) (142)
Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. (1996) (141)
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. (2002) (140)
Minimal Acute Rejection after Lung Transplantation: A Risk for Bronchiolitis Obliterans Syndrome (2005) (134)
Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. (1999) (133)
Early Posttransplant Inflammation Promotes the Development of Alloimmunity and Chronic Human Lung Allograft Rejection (2007) (132)
Bilateral sequential lung transplantation: the procedure of choice for double-lung replacement. (1991) (131)
Management of lung transplant rejection. (1993) (128)
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. (2007) (122)
Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. (2000) (118)
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. (2010) (117)
Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. (2010) (116)
Lung transplantation for pulmonary vascular disease. (2002) (116)
Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. (1992) (114)
Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report--2005. (2005) (113)
Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases. (2001) (111)
Primary graft dysfunction and other selected complications of lung transplantation: A single-center experience of 983 patients. (2005) (109)
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. (2000) (108)
Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. (2011) (107)
The Registry of the International Society for Heart and Lung Transplantation: Sixth Official Pediatric Report--2003. (2003) (107)
Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report--2004. (2004) (103)
Single‐Lung Transplantation for Pulmonary Hypertension: Three‐Month Hemodynamic Follow‐up (1991) (102)
Autoantibody formation after alloimmunization: are blood tranfusions a risk factor for autoimmune hemolytic anemia? (2004) (101)
Lung transplantation: a decade of experience. (1999) (99)
The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation. (1999) (96)
Outcome of patients with cystic fibrosis awaiting lung transplantation. (2000) (95)
Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. (1991) (92)
Cardiac and pulmonary replacement Single or bilateral lung transplantation for emphysema (1996) (91)
Lung transplantation for lymphangioleiomyomatosis. (2001) (90)
Detection of Severe Human Metapneumovirus Infection by Real-Time Polymerase Chain Reaction and Histopathological Assessment (2005) (88)
Indirect Allorecognition of Mismatched Donor HLA Class II Peptides in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome (2001) (87)
Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. (1995) (85)
Single lung transplantation for pulmonary hypertension. Technical aspects and immediate hemodynamic results. (1992) (83)
The Registry of the International Society for Heart and Lung Transplantation: Fifth Official Pediatric Report-2001 to 2002. (2002) (83)
Cardiopulmonary exercise testing after single and double lung transplantation. (1990) (81)
Lung transplant edema: chest radiography after lung transplantation--the first 10 days. (1995) (80)
Results of lung volume reduction surgery in patients with emphysema. The Washington University Emphysema Surgery Group. (1996) (75)
Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. (1992) (75)
Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis. (2019) (75)
The impact of cytolytic therapy on bronchiolitis obliterans syndrome. (1998) (74)
Telephone-based coping skills training for patients awaiting lung transplantation. (2006) (73)
Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations. (2013) (72)
Single lung transplantation for severe chronic obstructive pulmonary disease. Washington University Lung Transplant Group. (1989) (72)
ACTIVATION OF HUMAN AIRWAY EPITHELIAL CELLS BY NON-HLA ANTIBODIES DEVELOPED AFTER LUNG TRANSPLANTATION: A POTENTIAL ETIOLOGICAL FACTOR FOR BRONCHIOLITIS OBLITERANS SYNDROME1 (2001) (71)
The evolution of single lung transplantation for emphysema. The Washington University Lung Transplant Group. (1991) (71)
Interleukin-6 and interferon-γ gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation (2002) (71)
Induction of IL-10 Suppressors in Lung Transplant Patients by CD4+25+ Regulatory T Cells through CTLA-4 Signaling1 (2006) (71)
Pulmonary considerations of organ transplantation. Part 3. (1991) (70)
The registry of the International Society for Heart and Lung Transplantation: introduction to the Twentieth Annual Reports--2003. (2003) (68)
Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. (1998) (68)
The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry (2008) (66)
Pediatric and adult lung transplantation for cystic fibrosis. (1998) (62)
A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation. (2005) (62)
The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. (1993) (62)
Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: decline with resolution of rejection. (2000) (61)
Lung transplantation. Analysis of thirty-six consecutive procedures performed over a twelve-month period. The Washington University Lung Transplant Group. (1992) (60)
Management of dysfunction in the transplanted lung: experience with 7 clinical cases. Washington University Lung Transplant Group. (1992) (59)
Pulmonary considerations of organ transplantation. Part I. (1991) (58)
Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT international registry for thoracic organ transplantation. (2001) (57)
Neurobehavioral functioning and survival following lung transplantation. (2014) (57)
Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. (1998) (57)
Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. (1993) (57)
Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report--2006. (2006) (56)
Pulmonary considerations of organ transplantation. Part 2. (1991) (55)
Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation. (2010) (54)
Single or bilateral lung transplantation for emphysema? (1996) (52)
Reliability for grading acute rejection and airway inflammation after lung transplantation. (2005) (50)
Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience (2016) (50)
Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients. (2003) (49)
The Washington University-Barnes Hospital experience with lung transplantation. Washington University Lung Transplantation Group. (1991) (49)
Lung transplantation. (1992) (49)
Does donor cause of death affect the outcome of lung transplantation? (2002) (49)
Lung Transplantation of Ventilator-Dependent Patients (1992) (48)
Cytokine gene transcripts for tumor necrosis factor-α, interleukin-2, and interferon-γ in human pulmonary allografts (1995) (48)
Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. (1989) (48)
Sirolimus-induced leukocytoclastic vasculitis. (2002) (45)
MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation. (2015) (45)
Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. (2001) (44)
Lung transplantation for primary pulmonary hypertension. (2001) (43)
The new lung allocation system and its impact on waitlist characteristics and post-transplant outcomes. (2008) (41)
Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. (2001) (41)
Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. (2004) (40)
Lung transplantation. Report of the ATS workshop on lung transplantation. American Thoracic Society, Medical Section of the American Lung Association. (1993) (40)
Donor selection for single and double lung transplantation. Chest size matching and other factors influencing posttransplantation vital capacity. (1990) (40)
Differences in early results after single-lung transplantation. Washington University Lung Transplant Group. (1994) (40)
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. (1995) (39)
Pulmonary vascular permeability after lung transplantation. A positron emission tomographic study. (1992) (39)
Lung transplantation is warranted for stable, ventilator-dependent recipients. (2000) (38)
Comparison of basiliximab and antithymocyte globulin as induction agents after lung transplantation (2004) (38)
Bronchial dehiscence after lung transplantation: correlation of CT findings with clinical outcome. (1996) (37)
Molecular assessment of rejection and injury in lung transplant biopsies. (2019) (37)
The predictive value of bronchiolitis obliterans syndrome stage 0-p. (2004) (35)
Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection. (2010) (34)
Thrombotic Microangiopathy after Lung Transplantation (2005) (34)
IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. (2006) (33)
Does the presence of preoperative mild or moderate coronary artery disease affect the outcomes of lung transplantation? (2006) (32)
Bronchiolitis obliterans syndrome: pathogenesis and management. (2004) (32)
Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. (1995) (31)
Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart-lung transplantation report--2006. (2006) (31)
Pathologic regression of primary pulmonary hypertension in left native lung following right single-lung transplantation. (2001) (30)
Use of cyclosporine in lung transplantation. (2004) (30)
A single‐center experience of 1500 lung transplant patients (2018) (30)
Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. (2002) (30)
The impact of pre-transplant allosensitization on outcomes after lung transplantation. (2015) (30)
Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. (2003) (29)
Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection. (1995) (29)
Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. (1999) (29)
Acute flaccid paralysis syndrome associated with echovirus 19, managed with pleconaril and intravenous immunoglobulin. (2001) (28)
Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. (2002) (28)
Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States. (2019) (28)
The Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0-p (2004) (26)
Suggested guidelines for the use of tacrolimus in lung-transplant recipients. (1999) (26)
Lung Transplantation for COPD. (1998) (25)
Report of workshop on lymphangioleiomyomatosis (1999) (25)
Quantitative cultures of the cell fraction and supernatant of bronchoalveolar lavage fluid for the diagnosis of cytomegalovirus pneumonitis in lung transplant recipients. (1993) (24)
Pulmonary vascular permeability in interstitial lung disease. A positron emission tomographic study. (1992) (24)
Analysis of Referrals for Lung Transplantation (1991) (24)
Increased expression of HDJ-2 (heat shock protein 40) and heat shock protein 70 in biopsy specimens of transplanted human lungs. (1998) (24)
Acute allograft rejection after lung transplantation: diagnosis and therapy. (2003) (23)
Outcome of lung transplantation for patients requiring concomitant cardiac surgery. (2005) (23)
Elevated Soluble CD30 Correlates with Development of Bronchiolitis Obliterans Syndrome Following Lung Transplantation (2006) (22)
Lung Transplantation for α1-Antitrypsin Deficiency Emphysema (1996) (22)
Lung transplantation. (1997) (22)
Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. (2010) (22)
Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. (1995) (22)
Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation. (2010) (22)
Chest computed tomography imaging improves potential lung donor assessment (2019) (22)
Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts. (1997) (22)
Bilateral lung transplantation and pulmonary artery reconstruction in a patient with chronic obstructive pulmonary disease and a giant pulmonary artery aneurysm. (2003) (21)
Pseudomonas aeruginosa and acute rejection independently increase the risk of donor‐specific antibodies after lung transplantation (2020) (21)
Role of defensins in the pathogenesis of chronic lung allograft rejection. (2014) (21)
Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation. (2008) (20)
Evaluation and preoperative management of lung volume reduction surgery candidates. (1997) (19)
Flexible bronchoscopy in lung transplantation. (1999) (19)
Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome (2004) (18)
The Registry of the International Society for Heart and Lung Transplantation: past, present and future. (2002) (17)
Cytotoxic T lymphocytes directed against donor HLA class I antigens on airway epithelial cells are present in bronchoalveolar lavage fluid from lung transplant recipients during acute rejection. (1999) (17)
Pneumonia in the solid organ transplant patient. (2005) (17)
Lung and heart-lung transplantation: overview of results. (2001) (17)
Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17. (2012) (16)
Correlation of changes in oxygenation, lung water and hemodynamics after oleic acid‐induced acute lung injury in dogs (1984) (15)
The ISHLT transplant registry: moving forward. (2006) (15)
Respiratory responses to CO2 rebreathing in lung transplant recipients. (1994) (15)
Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2005 annual reports. (2005) (15)
Cardiac dysfunction during acute lung injury induced by oleic acid in dogs. (1986) (15)
Recent advances in surgery for emphysema. (1997) (14)
Clinical outcomes of solid organ transplant recipients with ehrlichiosis (2009) (14)
Pulmonary "twinning" procedure: use of lungs from one donor for single-lung transplantation in two recipients. (1992) (13)
Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. (2012) (13)
Are there predictors of death at the time of listing for lung transplant (2002) (13)
Registry of the International Society for Heart and Lung Transplantation: introduction to the 2007 annual reports--100,000 transplants and going strong. (2007) (13)
Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants (1993) (13)
Technical Considerations for Lung Transplantation in Kartagener's Syndrome. (2019) (12)
Lung Transplant or Bust: Patients' Recommendations for Ideal Lung Transplant Education (2014) (12)
Lung transplantation for alpha 1-antitrypsin deficiency emphysema. (1996) (12)
Retrieval by other procurement teams provides favorable lung transplantation outcome. (1997) (12)
Risk factors for death after lung transplant in the US (2003) (12)
Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction (2019) (11)
Falsely Elevated Plasma Creatinine Due to an Immunoglobulin M Paraprotein. (2016) (11)
Lung transplantation and bronchiolitis obliterans (2001) (11)
Impact of Delayed Chest Closure on Surgical Site Infection After Lung Transplantation. (2017) (11)
Lung transplantation in chronic airflow limitation. (1996) (9)
Critical Care Aspects of Lung Transplant Patients (2002) (9)
Arterial Blood Gases (1990) (8)
Cadaveric nerve allotransplantation in the treatment of persistent thoracic neuralgia. (2015) (8)
Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients (1999) (8)
Acute antibody-mediated rejection after lung transplantation. (2009) (8)
Tidal volume and respiratory rate changes during CO2 rebreathing after lung transplantation. (1994) (7)
Sarcoidosis in an adult with cystic fibrosis. (1989) (7)
Pulmonary Vascular Permeability in Interstitial Lung Disease (1992) (7)
Tissue-plasminogen activator for pulmonary embolism resulting in shock: two case reports and discussion of the literature. (1991) (7)
Economic evaluation of the specialized donor care facility for thoracic organ donor management (2020) (7)
The role of cardiopulmonary exercise testing in lung and heart-lung transplantation. (1994) (7)
Lung transplantation of ventilator-dependent patients. The Washington University Lung Transplantation Group. (1992) (6)
Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation. (2021) (6)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Study of Rabbit ATG in the Prophylaxis of Acute Rejection in Lung Transplantation (2014) (5)
LUNG TRANSPLANTATION : SPECIAL CONSIDERATIONS AND OUTCOME IN LAM (1999) (5)
351: Refining the identification of discriminatory genes for rejection in lung transplantation: The LARGO Study (2007) (5)
MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome. (2016) (5)
Circulating Mitochondrial DNA Is Elevated in Patients with Immediate Primary Graft Dysfunction (2013) (5)
The impact of lung transplantation on quality of life in patients with COPD (2005) (4)
14: Impact of the new lung allocation system in the United States (2007) (4)
A comparative analysis of basiliximab (SIMULECT®) and antithymocyte globulin (ATGAM®) for induction immunosuppression in clinical lung transplantation (2002) (4)
132: Airway Complications after Lung Transplantation: Incidence and Risk Factors in a Contemporary Series (2008) (4)
Pulmonary embolectomy after single-lung transplantation. (1997) (4)
Inter-reader and intra-reader agreement for grading acute rejection and airway inflammation after lung transplantation, based on the lung rejection study group revised working formulation (2003) (3)
Molecular Detection of Rejection-like Changes in Proximal Bronchial Mucosal Lung Transplant Biopsies: Initial Findings of the INTERLUNG Study (2018) (3)
[Lung volume reduction surgery in advanced emphysema--results of the Washington University, St. Louis]. (1996) (3)
The registry of the international society for heart and lung transplantation: Introduction to the 2004 Annual Reports (2004) (3)
Lung transplantation for lymphangioleiomyomatosis. (2001) (3)
Abdominal-pelvic lymphoproliferative disease after lung transplantation (2003) (3)
100: Immunoregulatory influences on peripheral blood gene expression in lung transplant patients: The lung allograft rejection gene expression observational (Largo) study (2006) (2)
Lobectomy to downsize donor lungs for use in small recipients (2003) (2)
Anatomic distortion of the right coronary artery as a complication of lung transplantation. (2010) (2)
Desensitization Therapy Before Lung Transplantation (2016) (2)
Lung Transplantation and Atrial Septostomy for Pulmonary Arterial Hypertension (2008) (2)
85 Antibody-Mediated Rejection after Lung Transplantation (2011) (2)
RESPIRATORY INFECTIONS IN IMMUNOCOMPROMISED PATIENTS (1993) (2)
Ganciclovir for cytomegalovirus after heart transplantation. (1992) (2)
Lung Allocation Score Exception Requests Submitted to the OPTN/UNOS Lung Review Board: Characteristics and Trends (2015) (2)
Allosensitization Increases the Risk of Death on the Lung Transplant Waiting List (2014) (2)
Interleukin-6 and interferon-&ggr; gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation1 (2002) (1)
C4d-Negative Antibody-Mediated Rejection After Lung Transplantation (2016) (1)
Acute Graft Versus Host Disease After Lung Transplantation (2010) (1)
196: Variability in the Pathologic Interpretation of Trans-Bronchial Lung Biopsy after Lung Transplantation. Clinical Implications (2008) (1)
Uncertainty analysis of chest X-ray lung height measurements and size matching for lung transplantation (2022) (1)
ncreased erythrocyte C 4 D is associated with known lloantibody and autoantibody markers of antibody-mediated ejection in human lung transplant recipients (2012) (1)
OR15 De novo development of DSA following human lung transplantation is associated with changes on circulating micro-RNA involved in T and B cell regulation and fibrogenesis (2015) (1)
Extracorporeal Photopheresis (ECP) in the Management of Chronic Lung Allograft Dysfunction (2019) (1)
Lung transplantation in recipients with previous lung volume reduction surgery (2003) (1)
MicroRNA 144 Involved in the Modulation of TGF-b Signaling and Fibrosis Is Upregulated in Lung Biopsies from Transplant Recipients Undergoing Chronic Rejection - Bronchiolitis Obliterans Syndrome (BOS): 2420 (2012) (1)
237: The impact of induction on survival after lung transplantation: An analysis of the ISHLT registry (2006) (1)
442 An Evaluation of the Impact of Statin Use on the Progression to Bronchiolitis Obliterans in Lung Allografts (2011) (1)
A 35-year-old woman with cough, dyspnea, and an abnormal chest radiograph. (1998) (1)
Risk Factors for the Development of Donor-specific Antibodies and Their Impact on Outcomes After Lung Transplantation (2018) (1)
Abstract239: A prospective randomized study of tacrolimus vs. cyclosporine after lung transplantation (2006) (1)
Analysis of referrals for lung transplantation. The Washington University Lung Transplantation Group. (1991) (1)
Lack of chronic lung allograft rejection is associated with expansion of regulatory CD4+CD25+ and CD4+CD28- T cells and a predominant Th2 alloreactivity (2004) (1)
138: Impact of primary graft dysfunction on bronchiolitis obliterans syndrome after lung transplantation (2007) (1)
303 Pre-Transplant Antibodies to Self-Antigens and the Subsequent Development of Donor-Specific HLA Antibodies after Lung Transplantation (2012) (1)
Pre-Transplant Antibodies to Kα1Tubulin and Collagen V in Lung Transplantation: Correlation with Disease, Primary Graft Dysfunction, Donor Specific HLA Antibodies, and Chronic Rejection (2013) (1)
Epithelial specific, non-MHC antibodies, induce hyperacute rejection of human lung allografts (2005) (1)
233 Epitope Switch of Self-Antigen Collagen V Is Associated with Th-17 Phenotype and Autoimmune Responses: Role in Chronic Rejection Following Human Lung Transplantation (2011) (0)
T Cells through CTLA-4 Signaling Regulatory + 25+ Transplant Patients by CD4 Induction of IL-10 Suppressors in Lung (2006) (0)
Introduction: infectious complications of organ transplantation. (1993) (0)
Complement-Fixing Donor-Specific Antibodies After Lung Transplantation (2014) (0)
Venous Thromboembolic Events after Recombinant Activated Factor VII in Lung Transplant Recipients (2013) (0)
Management of patients after lung transplantation (1999) (0)
Immunological link among pretransplant autoantibodies, primary lung allograft dysfunction (PGD), and chronic human lung allograft rejection (BOS) (2009) (0)
89-P Significance of C1q-fixing donor specific antibodies (DSA) following human lung transplantation (2011) (0)
Outcomes of Lung Transplantation in Septuagenarian Recipients (2018) (0)
Approaches to deep venous thrombosis and pulmonary embolism in aging patients. (1988) (0)
31: Innate Immune Activation by Hyaluronan Leads to Inflammation and Loss of Regulatory T Cells Resulting in Development of BOS Following Human Lung Transplantation (2009) (0)
Antibody mediated rejection following human lung transplantation (2004) (0)
Mohanakumar Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients (0)
Hypersensitivity to self proteins might be a pathoimmunological derangement leading to chronic rejection after lung transplantation (2004) (0)
Liclinical investigations - Lung Transplantation of Ventilator-Dependent Patients* (2015) (0)
Humoral immune responses in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation (2005) (0)
REGULATION OF AUTOIMMUNITY BY CD4+CD25+ T-CELLS (Tregs) FOLLOWING LUNG TRANSPLANTATION. (2006) (0)
39-OR: Immunological link between primary lung allograft dysfunction (PGD) and chronic rejection (BOS) (2007) (0)
Acute Antibody-Mediated Rejection After Lung Transplantation: A Retrospective, Single Center, Case Series (2013) (0)
165: CD4+25+ T-cell mediated regulation of autoimmunity following human lung transplantation (2006) (0)
Autoimmunity to collagen-V may lead to chronic rejection after human lung transplantation (2005) (0)
Bronchiolitis-obliterans syndrome-free survival following lung transplantation - an International Society for Heart and Lung Transplantation (ISHLT) Thoracic Transplant Registry analysis (2019) (0)
Immune response to non-MHC airway epithelial cell antigen(s) promotes chronic lung allograft rejection (2005) (0)
cute Antibody-mediated Rejection After Lung Transplantation (2008) (0)
Dysregulation of autoimmunity to collagen V (col-V) and development of BOS following human lung transplantation (2006) (0)
Lung transplant with concomitant cardiac surgery: results and long-term survival (2004) (0)
Molecular Analysis of Transbronchial and Mucosal Biopsies in Patients with CLAD (2019) (0)
Lung transplantation at Barnes-Jewish Hospital and Washington University in St. Louis. (2010) (0)
52-P: Functional relevance of donor specific antibody detected by immunoassay following lung transplant (2008) (0)
Molecular Detection of Community Acquired Respiratory Viral Infections (CARV) and the Risk of BOS in Lung Transplant (LTx) Recipients (2016) (0)
DEVELOPMENT OF ANTI-AIRWAY EPITHELIAL CELL SPECIFIC ANTIBODIES IN LUNG TRANSPLANT RECIPIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME (1999) (0)
Outcomes After Lung Transplantation in the Elderly (2018) (0)
Increased expression of CD40, B7–2, interleukin-15 and granzyme B in bronchoalveolar lavage cells from human lung transplant recipients (2003) (0)
Three-Month Hemodynamic Follow-up (2005) (0)
415: Pre-Transplant Allosensitization Is a Barrier to Lung Transplantation (2010) (0)
48-OR: Collagen V Epitope Constraint Leading to Cytokine Switch Following Alloimmune Responses to Mismatched MHC Class I Antigens Which Induces Autoimmunity and Chronic Rejection (2010) (0)
Risk Factors Associated with Airway Complications after Lung Transplantation (2019) (0)
nti-human leukocyte antigen antibodies and preemptive ntibody-directed therapy after lung transplantation (2011) (0)
ELEVATED SOLUBLE CD30 LEVELS CORRELATE WITH ONSET OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS) IN LUNG TRANSPLANT PATIENTS (2006) (0)
ELEVATED SOLUBLE CD30 LEVELS CORRELATE WITH ONSET OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS) IN LUNG TRANSPLANT PATIENTS (2006) (0)
Post-operative atrial dysrhythmias after lung transplantation (2004) (0)
392: Interaction between α-1-Antitrypsin (AAT) and A-Defensins in Regulating Immune Responses Leading to Chronic Rejection Following Human Lung Transplantation (2010) (0)
82 Antibody Directed Therapy for DSA Results in Diminished Autoimmune Response and Favorable Long Term Outcome Following Human Lung Transplantation (2011) (0)
nterventional and Surgical Modalities of reatment for Pulmonary Arterial Hypertension (2004) (0)
443 Rabbit Anti-Thymocyte Globulin for the Management of BOS after Lung Transplantation (2011) (0)
Single Versus Double Lung Transplantation in the Setting of Constrained Donor Availability (2016) (0)
Lung translplantation in chronic airflow limitation (1996) (0)
156: The Efficacy of Photopheresis in Lung Transplantation (2009) (0)
340 Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Cause Abrogation of Obliterative Airways Disease (2011) (0)
Proteasome Inhibitor Therapy for Antibody-Mediated Lung Transplant Rejection (2013) (0)
1034-LBO: Differential microRNA expression profiling in lung allograft recipients who develop donor specific antibody and Bronchiolitis Obliterans Syndrome (2014) (0)
(959) - Bronchiolitis-Obliterans Syndrome-Free Survival of Lung Transplant Recipients - Analysis of the ISHLT Registry (2017) (0)
231 Respiratory Viruses Convert CD4+CD25+Foxp3+Regulatory T Cells (Tregs) into Th-17 Cells: Role in Promoting Autoimmunity and Chronic Lung Allograft Rejection (2011) (0)
306: Respiratory Viral Infections through TLR7 Signaling Lead to Loss of Tregs and Contribute to Development of Chronic Rejection (BOS) Following Lung Transplantation (2009) (0)
Microbiome Profiling by Whole Genome Sequencing During Acute and Chronic Lung Transplant Rejection (2014) (0)
Long-term outcomes of single and bilateral lung transplantation for adults with Pulmonary Arterial Hypertension (2005) (0)
Expression of CD40 and granzyme B in bronchoalveolar lavage cells from human lung transplant recipients (2002) (0)
447: Impact of the New Lung Allocation System in the US: A Single Center Study (2008) (0)
245: Pro-inflammatory Th1-cytokines and HLA class-II alloimmunity may predispose to chronic human lung allograft rejection (2006) (0)
302: Alloimmunity Induced Remodeling of Airway Epithelium Exposes Cryptic Self Antigens (Kα1 Tubulin & CollagenV), Leading to Autoimmunity and Chronic Rejection Following Human Lung Transplantation (2009) (0)
72-P: Early Detection and Reduction of Donor Specific Antibody (DSA) in Post Lung Transplant Patients (2010) (0)
244: Identification of a unique airway epithelial cell antigen defined by post-transplant sera from human lung transplant recipients with brochiolitis obliterans syndrome capable of protein kinase C activation and fibrotic growth factor production (2006) (0)
[Bilateral volume reduction for surgical treatment of advanced lung emphysema]. (1996) (0)
421: Effect of induction therapy on the peripheral blood genomic signature in the LARGO lung transplant study (2007) (0)
Efficacy of thymoglobulin® for the treatment of bos after lung transplantation and predictors of a therapeutic response (2004) (0)
Role of Donor Microbiota in the Development of Primary Graft Dysfunction Following Human Lung Transplantation (2016) (0)
Immunosuppressive therapy for lung transplantation (1991) (0)
Lung transplantation and COPD (2002) (0)
63-P: Post transplant DSA monitoring following lung transplantation (2007) (0)
14: Anti-HLA Antibodies and Antibody-Directed Therapy after Lung Transplantation (2009) (0)
Locoregional dendritic cells (DCs) from virus-infected recipients can convert CD4+CD25+Foxp3+ regulatory T cells (Tregs) into Th17-cells and promote autoimmunity (2009) (0)
323: Alloimmune Responses to Mismatched MHC Class I Antigens Induces Immune Responses to Self Antigens Leading to Chronic Rejection (2010) (0)
35-P: Does HLA donor specific antibody strength in post transplant lung patients correlate with pulmonary function tests? (2008) (0)
A Pilot Randomized Placebo Controlled Trial of Inhaled Beclomethasone after Community-Acquired Respiratory Viral (CARV) Infection in Lung Transplant Recipients (LTR) (2019) (0)
53-P: The Impact of Allosensitization on Time to Transplantation and Mortality in a Cohort of Patients Awaiting Lung Transplantation (2010) (0)
210: Bacterial Isolation from Respiratory Specimens and the Risk of Bronchiolitis Obliterans Syndrome (2009) (0)
Molecular Diagnosis of Rejection Phenotypes in Lung Transplant Biopsies: Initial Findings of the INTERLUNG Study (2018) (0)
(626) - Histoplasmosis in Adult Lung Transplant Recipients (2017) (0)
32: Role of ImmuKnow Assay Following Lung Transplantation (2010) (0)

This paper list is powered by the following services:

Elbert P. Trulock's Academic­Influence.com Rankings

Why Is Elbert P. Trulock Influential?

Elbert P. Trulock's Published Works

Published Works

Elbert P. Trulock's AcademicInfluence.com Rankings